$PRME Balance Sheet | Understand Stock

$PRME

$4.35 +$0.74 (20.5%) Close

$PRME Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Nonrelated Party
Related Party
Total short-term investments
Short-term investment — related party
Prepaid expenses and other current assets
Collaboration receivable — related party
Prepaid expenses
Other current assets
Total current assets

Property and equipment, net
Operating lease right-of-use assets
Restricted cash
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Related Party
Total accounts payable
Accrued expenses and other current liabilities
Nonrelated Party
Related Party
Total accrued expenses and other current liabilities
Related party forward contract liability
Accrued settlement payment — related party
Deferred revenue — related party
Operating lease liability
Total current liabilities

Deferred revenue, net of current — related party
Operating lease liability, net of current
Non current deferred tax liability
Research and development funding liability
Total liabilities
Redeemable convertible and convertible preferred stock, carrying amount
Series A Redeemable Convertible Preferred Stock
Series B Convertible Preferred Stock
Total redeemable convertible and convertible preferred stock, carrying amount

Stockholders’ equity
Common stock, par value of $0.00001 per share; 775,000,000 shares authorized; 180,737,548 and 180,514,014 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Redeemable convertible and convertible preferred stock, shares authorized (in shares)
Series A Redeemable Convertible Preferred Stock
Series B Convertible Preferred Stock
Total redeemable convertible and convertible preferred stock, shares authorized (in shares)
Redeemable convertible and convertible preferred stock, shares issued (in shares)
Series A Redeemable Convertible Preferred Stock
Series B Convertible Preferred Stock
Total redeemable convertible and convertible preferred stock, shares issued (in shares)
Redeemable convertible and convertible preferred stock, shares outstanding (in shares)
Series A Redeemable Convertible Preferred Stock
Series B Convertible Preferred Stock
Total redeemable convertible and convertible preferred stock, shares outstanding (in shares)

Comments